Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Psychological distress is associated with cancer-specific mortality among patients with cervical cancer.

Lu D, Andrae B, Valdimarsdóttir U, Sundström K, Fall K, Sparén P, Fang F.

Cancer Res. 2019 Jun 28. pii: canres.0116.2019. doi: 10.1158/0008-5472.CAN-19-0116. [Epub ahead of print]

PMID:
31253667
2.

Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.

Wang J, Elfström KM, Andrae B, Nordqvist Kleppe S, Ploner A, Lei J, Dillner J, Sundström K, Sparén P.

Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32416. [Epub ahead of print]

PMID:
31107987
3.

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.

Lei J, Andrae B, Ploner A, Lagheden C, Eklund C, Nordqvist Kleppe S, Wang J, Fang F, Dillner J, Elfström KM, Sparén P.

BMJ. 2019 Apr 3;365:l1207. doi: 10.1136/bmj.l1207.

4.

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.

Lei J, Ploner A, Lagheden C, Eklund C, Nordqvist Kleppe S, Andrae B, Elfström KM, Dillner J, Sparén P, Sundström K.

PLoS Med. 2018 Oct 1;15(10):e1002666. doi: 10.1371/journal.pmed.1002666. eCollection 2018 Oct.

5.

[Cervical cancer has increased in Sweden in women who had a normal cell sample].

Dillner J, Sparén P, Andrae B, Strander B.

Lakartidningen. 2018 Jun 5;115. pii: E9FD. Swedish.

6.

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer.

Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J.

Br J Cancer. 2018 May;118(10):1377-1381. doi: 10.1038/s41416-018-0053-6. Epub 2018 Mar 21.

7.

Replik till Erik Wilander: - Okänd orsak till ökning av cervixcancer.

Dillner J, Andrae B, Strander B, Sparén P.

Lakartidningen. 2018 Feb 26;115. pii: E3HS. Swedish. No abstract available.

PMID:
29485668
Free Article
8.

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.

Wang J, Andrae B, Sundström K, Ploner A, Ström P, Elfström KM, Dillner J, Sparén P.

PLoS Med. 2017 Oct 24;14(10):e1002414. doi: 10.1371/journal.pmed.1002414. eCollection 2017 Oct.

9.

Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.

Sundström K, Lu D, Elfström KM, Wang J, Andrae B, Dillner J, Sparén P.

Am J Obstet Gynecol. 2017 Jan;216(1):48.e1-48.e15. doi: 10.1016/j.ajog.2016.07.042. Epub 2016 Jul 25.

10.

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, Arnheim-Dahlström L, Dillner J, Sparén P.

BMJ. 2016 Feb 11;352:i276. doi: 10.1136/bmj.i276.

11.

School-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study.

Grandahl M, Rosenblad A, Stenhammar C, Tydén T, Westerling R, Larsson M, Oscarsson M, Andrae B, Dalianis T, Nevéus T.

BMJ Open. 2016 Jan 27;6(1):e009875. doi: 10.1136/bmjopen-2015-009875.

12.

[Does screening for HPV solve more problems than it creates?].

Strander B, Andrae B.

Lakartidningen. 2013 Jun 5-18;110(23-24):1170. Swedish. No abstract available.

PMID:
23847874
13.

Trust versus concerns-how parents reason when they accept HPV vaccination for their young daughter.

Gottvall M, Grandahl M, Höglund AT, Larsson M, Stenhammar C, Andrae B, Tydén T.

Ups J Med Sci. 2013 Nov;118(4):263-70. doi: 10.3109/03009734.2013.809039. Epub 2013 Jun 19.

14.

Screening and cervical cancer cure: population based cohort study.

Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S, Sparén P.

BMJ. 2012 Mar 1;344:e900. doi: 10.1136/bmj.e900.

15.

[New guidelines for prevention of cervix cancer. ARG report on investigation and treatment of abnormal cytological smears].

Strander B, Elfgren K, Andrae B.

Lakartidningen. 2011 Mar 9-15;108(10):533-5. Swedish. No abstract available.

PMID:
21744553
16.

Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study.

Silfverdal L, Kemetli L, Sparén P, Andrae B, Strander B, Ryd W, Dillner J, Törnberg S.

Int J Cancer. 2011 Sep 15;129(6):1450-8. doi: 10.1002/ijc.25749. Epub 2010 Dec 9.

17.

The challenges of organising cervical screening programmes in the 15 old member states of the European Union.

Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, Andrae B.

Eur J Cancer. 2009 Oct;45(15):2671-8. doi: 10.1016/j.ejca.2009.07.016. Epub 2009 Aug 18.

PMID:
19695867
18.

Value of high-risk HPV-DNA testing in the triage of ASCUS.

Silverloo I, Andrae B, Wilander E.

Acta Obstet Gynecol Scand. 2009;88(9):1006-10. doi: 10.1080/00016340903160952.

PMID:
19690991
19.

Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.

Silfverdal L, Kemetli L, Andrae B, Sparén P, Ryd W, Dillner J, Strander B, Törnberg S.

Am J Obstet Gynecol. 2009 Aug;201(2):188.e1-7. doi: 10.1016/j.ajog.2009.04.006. Epub 2009 Jun 26.

PMID:
19560117
20.

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.

J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.

PMID:
18445828
21.

[Organized improvement of cervix cancer prevention].

Andrae B, Elfgren K, Strander B.

Lakartidningen. 2008 Feb 6-12;105(6):378-9. Swedish. No abstract available.

PMID:
18380357
22.

[Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].

Dillner J, Andrae B, Westermark B.

Lakartidningen. 2006 Nov 1-7;103(44):3377-9. Swedish. No abstract available.

PMID:
17152260
23.

[Who is to be vaccinated against cervix cancer and when? Proposal to counseling points].

Björn S, Bengt A, Kristina E.

Lakartidningen. 2006 Nov 8-14;103(45):3438. Swedish. No abstract available.

PMID:
17140172
24.

[Cervix cancer prevention--achieved success must be surpassed].

Bengt A, Strander B.

Lakartidningen. 2006 May 17-30;103(20):1630; author reply 1630. Swedish. No abstract available.

PMID:
16800092
25.

[HPV testing--the effect must be evaluated prior to clinical use!].

Persson E, Andrae B, Strander B.

Lakartidningen. 2002 May 30;99(22):2552. Swedish. No abstract available.

PMID:
12092058

Supplemental Content

Loading ...
Support Center